The latest market report published by Credence Research, Inc. “Global Breast Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” reports that alarming incidence of breast cancer and oncoming trend of minimally invasive and guided cancer diagnostics will drive the global breast biopsy devices market.
Browse the full report Breast Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/breast-biopsy-devices-market
Adoption of Magnetic Resonance Imaging (MRI) for locating and evaluating breast lesions is on a perpetual increase. Breast MRI delivers high sensitivity and low specificity in evaluating breast abnormalities and lesions. As the demand for breast MRI imaging is on the rise, the demand for MEI-guided breast interventions will also increase correspondingly. MRI guided sampling of breast tissue can be performed by wire localization, fine needle aspiration, large core needle biopsy and also by vacuum assisted biopsy.
MRI systems of high strengths, such as 3 Tesla and above are being increasingly installed in clinical practice. Ability of acquiring higher resolution images in the shortest possible time, makes 3T machines a better alternative to 1.5T imaging equipment for breast diagnosis. Reduction in MR data time while maintaining spatial resolution and signal to noise ratio further urges adoption of high resolution MRI equipment an appealing option for breast intervention. MRI guided breast biopsy is indicated in abnormalities and lesions where detection through ultrasound and mammography is challenged.
Efficiency of MRI guided breast biopsy in minimizing diagnostic costs, improving diagnostic outcomes and patient comfort, safety in terms of radiation exposure against stereotactic X-ray guided breast biopsy, and better accuracy are some of the prime factors that drive the global MRI guided breast biopsy market. The global MRI guided breast biopsy market is expected to progress at a CAGR of 12.08% during the forecast period 2016 to 2022.
Browse the full report Breast Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/breast-biopsy-devices-market
Table of Content
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Breast Biopsy Devices Market, by Biopsy Type, 2015 (USD Mn)
2.2 Breast Biopsy Devices Market Share, by Product Type, 2015 & 2022 (Value %)
2.3 Breast Biopsy Devices Market, by Guidance Type, 2015 (USD Mn)
2.4 Breast Biopsy Devices Market Share, by Geography, 2015 (Value %)
2.1 Breast Biopsy Devices Market, by Biopsy Type, 2015 (USD Mn)
2.2 Breast Biopsy Devices Market Share, by Product Type, 2015 & 2022 (Value %)
2.3 Breast Biopsy Devices Market, by Guidance Type, 2015 (USD Mn)
2.4 Breast Biopsy Devices Market Share, by Geography, 2015 (Value %)
Chapter 3 Breast Biopsy Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.1.1 Breast Cancer Estimated Incidence & Mortality, Worldwide (2012)
3.2 Drivers
3.2.1 Population Aging Contributing to Mandate for Cancer Diagnostics
3.2.1.1 Age-specific Breast Cancer Rates: United States
3.2.1.2 Age Statistics Above 65, by Key Countries, 2015 - 2030
3.2.2 Excessive Disease Prevalence
3.2.2.1 Estimated Incidence, Mortality and Prevalence of Breast Cancer, Worldwide, 2012
3.3 Challenges
3.3.1 High Costs of Biopsy May Constrain Growth
3.3.2 Susceptibility to Radiation Exposure
3.4 Future Prospects
3.4.1 Integrated Breast Centers
3.5 Impact Analysis of Drivers and Challenges During the Forecast Period
3.6 Attractive Investment Proposition
3.1 Introduction, Facts and Figures
3.1.1 Breast Cancer Estimated Incidence & Mortality, Worldwide (2012)
3.2 Drivers
3.2.1 Population Aging Contributing to Mandate for Cancer Diagnostics
3.2.1.1 Age-specific Breast Cancer Rates: United States
3.2.1.2 Age Statistics Above 65, by Key Countries, 2015 - 2030
3.2.2 Excessive Disease Prevalence
3.2.2.1 Estimated Incidence, Mortality and Prevalence of Breast Cancer, Worldwide, 2012
3.3 Challenges
3.3.1 High Costs of Biopsy May Constrain Growth
3.3.2 Susceptibility to Radiation Exposure
3.4 Future Prospects
3.4.1 Integrated Breast Centers
3.5 Impact Analysis of Drivers and Challenges During the Forecast Period
3.6 Attractive Investment Proposition
Chapter 4 Global Breast Biopsy Market Analysis, by Biopsy Type
4.1 Preface
4.2 Fine Needle Aspiration Biopsy (FNAB)
4.3 Core Needle Biopsy (CNB)
4.4 Vacuum Assisted Breast Biopsy (VABB)
4.5 Incisional and Excisional Breast Biopsy
4.1 Preface
4.2 Fine Needle Aspiration Biopsy (FNAB)
4.3 Core Needle Biopsy (CNB)
4.4 Vacuum Assisted Breast Biopsy (VABB)
4.5 Incisional and Excisional Breast Biopsy
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States
CA 95103, United States
Ph.: 1-800-361-8290
E-mail: sales@credenceresearch.com
Website: http://www.credenceresearch.com
No comments:
Post a Comment